Skip to main content

Arlington Partners LLC

Position in NVO — Novo Nordisk A S

CIK 1389848 BIRMINGHAM, AL

Position in NVO

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$324,889
+$86,235 QoQ
Shares Held
6,777
+4.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.67%
of 13F equity value
Holder Rank
#861
of 1,348 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Arlington Partners LLC holds $1,299,554 across 5 Drug Manufacturers - General names. NVO ranks #1 (25.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
This page
6,777 $324,889

All Filings in NVO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $324,889 6,777
2026-03-31 $238,654 6,494
2025-09-30 $5,160,902 93,006
2025-06-30 $4,560,703 66,078
2025-03-31 $3,426,516 49,345
2024-12-31 $2,530,020 29,412
2024-09-30 $3,502,086 29,412
2024-06-30 $3,351,106 23,477
2024-03-31 $3,486,958 27,157
2023-12-31 $3,121,603 30,175
2023-09-30 $2,851,150 31,352
2023-06-30 $2,218,851 13,711
2023-03-31 $2,181,968 13,711
2022-12-31 $2,704,905 19,986
2022-09-30 $1,991,205 19,986
2022-06-30 $2,191,048 19,663
2022-03-31 $2,737,937 24,655
2021-12-31 $3,173,072 28,331
2021-09-30 $3,099,970 32,288
2021-06-30 $3,596,413 42,932
2021-03-31 $2,826,853 41,929
2020-12-31 $2,475,763 35,444
2020-09-30 $2,431,855 35,026
2020-06-30 $2,293,502 35,026
2020-03-31 $2,320,770 38,551